Insider screener

Period: 12 months Role: Other officers × Plan: Scheduled (10b5-1) × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

10,625 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

10,625 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

10,625 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

10,625 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
10,625 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
10,625 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

10,625 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
9 Mar 2026
Lemasney Mark EVP Power Generation Division
Sold on a plan
$347.09K 3,845 at 90.27
29.9%
Planned (10b5-1)
9 Mar 2026
Brosius Mark SVP & Chief Mfg and Supply Cha
Sold on a plan
$312.83K 645 at 485.01
28.6%
Planned (10b5-1)
9 Mar 2026
Breeden John E Chief Delivery Officer
Sold on a plan
$312.00K 6,076 at 51.35
6.7%
Planned (10b5-1)
9 Mar 2026
Taira Thomas President, Special Projects
Sold on a plan
$309.73K 953 at 325.00
1.4%
Planned (10b5-1)
9 Mar 2026
Mutz Christopher HEAD OF RARE DISEASE
Sold on a plan
$267.20K 3,602 at 74.18
3.7%
Planned (10b5-1)
9 Mar 2026
Foley Douglas SVP, HR & Administration
Sold on a plan
$263.94K 1,600 at 164.96
5.7%
Planned (10b5-1)
9 Mar 2026
Dieter David EVP & General Counsel
Sold on a plan
$228.11K 6,224 at 36.65
6.4%
Planned (10b5-1)
9 Mar 2026
Rutledge Kimberly Anne Chief People Officer
Sold on a plan
$222.86K 4,340 at 51.35
4.9%
Planned (10b5-1)
9 Mar 2026
Lucas Shannon President & COO · indirect
Sold on a plan
$213.29K 11,700 at 18.23
0.7%
Planned (10b5-1)
9 Mar 2026
Sundaram Mani EVP and GM Security · indirect
Sold on a plan
$169.75K 1,722 at 98.58
7.4%
Planned (10b5-1)
9 Mar 2026
Kerr Michael S General Counsel
Sold on a plan
$144.86K 2,821 at 51.35
5.6%
Planned (10b5-1)
9 Mar 2026
Benjamin Richard J Chief Medical Officer
Sold on a plan
$76.03K 40,426 at 1.88
4.4%
Planned (10b5-1)
9 Mar 2026
Goins Melanie F General Counsel and CPO
Sold on a plan
$67.36K 12,248 at 5.50
5.2%
Planned (10b5-1)
9 Mar 2026
Rodman David Malcom Chief Medical Officer
Sold on a plan
$58.27K 2,171 at 26.84
2.6%
Planned (10b5-1)
9 Mar 2026
Yi Steven See Remarks
Sold on a plan
$55.72K 5,650 at 9.86
0.2%
Planned (10b5-1)
9 Mar 2026
Wittmann Michael Chief Operating Officer
Sold on a plan 2×
$47.59K 18,750 at 2.54
12.6%
Planned (10b5-1)
9 Mar 2026
Sisulak Jon J Controller
Sold on a plan
$41.63K 977 at 42.61
6.4%
Planned (10b5-1)
9 Mar 2026
Dowden Nathan J President & COO
Sold on a plan
$40.58K 3,116 at 13.02
1.5%
Planned (10b5-1)
9 Mar 2026
Pilkington Kyle CHIEF LEGAL OFFICER
Sold on a plan
$30.00K 25,000 at 1.20
3.1%
Planned (10b5-1)
9 Mar 2026
Varkey Johnson SVP-Chief Information Officer
Sold on a plan
$29.68K 121 at 245.27
1.3%
Planned (10b5-1)
9 Mar 2026
DeSantis Christopher P. SVP Operations - East
Sold on a plan
$14.98K 61 at 245.50
0.6%
Planned (10b5-1)
9 Mar 2026
Carroll John A. VP & Chief Accounting Officer
Sold on a plan
$11.53K 47 at 245.30
0.5%
Planned (10b5-1)
6 Mar 2026
Pate R. Hewitt Chief Legal Officer
Sold on a plan
$9.07M 47,200 at 192.12
84.7%
Sold half or more
6 Mar 2026
Kastelein Johannes Jacob Pieter Chief Scientific Officer · indirect
Sold on a plan
$2.85M 94,124 at 30.32
57.6%
Sold half or more
6 Mar 2026
Morris John J President & COO
Sold on a plan
$1.96M 7,979 at 245.07
7.5%
Planned (10b5-1)
6 Mar 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan 5×
$1.65M 8,398 at 196.08
3.5%
Planned (10b5-1)
6 Mar 2026
Simmons Donald E. Group President, Americas
Sold on a plan
$1.59M 3,762 at 422.70
49.6%
Planned (10b5-1)
6 Mar 2026
Cash Paul F General Counsel & Corp. Secy.
Sold on a plan 4×
$1.51M 19,800 at 76.09
41.5%
Planned (10b5-1)
6 Mar 2026
Frost Bert A EVP, Chief Commercial Officer
Sold on a plan
$1.19M 10,000 at 119.01
10.3%
Planned (10b5-1)
6 Mar 2026
Feng Lisa See remarks
Sold on a plan 2×
$691.15K 15,000 at 46.08
23.1%
Planned (10b5-1)
6 Mar 2026
Phillips Dominic SEE REMARKS
Sold on a plan
$565.12K 17,808 at 31.73
3.0%
Planned (10b5-1)
6 Mar 2026
Rock Stacey G President, KTT Division
Sold on a plan 6×
$533.74K 6,066 at 87.99
19.1%
Planned (10b5-1)
6 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$468.45K 30,941 at 15.14
4.5%
Planned (10b5-1)
6 Mar 2026
Lucas Shannon President & COO · indirect
Sold on a plan
$444.00K 23,884 at 18.59
1.5%
Planned (10b5-1)
6 Mar 2026
Hunsaker Craig E EVP, PEOPLE & CULTURE
Sold on a plan
$410.62K 33,602 at 12.22
1.8%
Planned (10b5-1)
6 Mar 2026
Morgan Anthony GROUP PRESIDENT
Sold on a plan
$380.66K 8,500 at 44.78
18.5%
Planned (10b5-1)
6 Mar 2026
Brosius Mark SVP & Chief Mfg and Supply Cha
Sold on a plan
$317.64K 648 at 490.19
22.3%
Planned (10b5-1)
6 Mar 2026
RUSSELL HEATHER J EVP, Chief Legal Officer
Sold on a plan
$314.66K 4,067 at 77.37
9.0%
Planned (10b5-1)
6 Mar 2026
Ruddy Marcella K. Chief Medical Officer
Sold on a plan
$300.00K 10,000 at 30.00
12.5%
Planned (10b5-1)
6 Mar 2026
Elwell Elizabeth A. VP & Chief Accounting Officer
Sold on a plan
$268.42K 635 at 422.71
8.2%
Planned (10b5-1)
6 Mar 2026
Liu Curtis Chief Technology Officer
Sold on a plan
$265.84K 33,201 at 8.01
5.2%
Planned (10b5-1)
6 Mar 2026
FAHS L READE Executive Chairman
Sold on a plan
$224.84K 7,601 at 29.58
1.1%
Planned (10b5-1)
6 Mar 2026
WHALEN CHAD MICHAEL EVP, Worldwide Sales
Sold on a plan
$190.61K 688 at 277.05
2.5%
Planned (10b5-1)
6 Mar 2026
McNamara Peter Chief Scientific Officer
Sold on a plan 2×
$188.94K 6,262 at 30.17
10.2%
Planned (10b5-1)
6 Mar 2026
Sold on a plan 2×
$158.67K 33,438 at 4.75
2.2%
Planned (10b5-1)
6 Mar 2026
Mutz Christopher HEAD OF RARE DISEASE
Sold on a plan
$157.42K 2,121 at 74.22
2.0%
Planned (10b5-1)
6 Mar 2026
Fruge Mary Celeste VP, General Counsel
Sold on a plan
$149.30K 11,193 at 13.34
4.0%
Planned (10b5-1)
6 Mar 2026
McKeon Timothy Senior VP and Treasurer
Sold on a plan
$132.19K 3,846 at 34.37
4.5%
Planned (10b5-1)
6 Mar 2026
FAHS L READE Executive Chairman · indirect
Sold on a plan
$120.38K 4,071 at 29.57
1.1%
Planned (10b5-1)
6 Mar 2026
Nottebohm Olivia Chief Operating Officer
Sold on a plan
$118.90K 4,612 at 25.78
1.0%
Planned (10b5-1)
Showing 6,801–6,850 of 10,625. ← Newer Page 137 of 213 Older →